Eli Lilly and Company makes the diabetes drug Trulicity and the cancer drug Verzenio.
Founded in 1876 by Colonel Eli Lilly, the Indianapolis-based company developed from a regional pharmaceutical manufacturer into a major global drugmaker. Its products cover diabetes, oncology, immunology, neuroscience, and other medical fields.
Trulicity is the brand name for dulaglutide, a glucagon-like peptide-1 receptor agonist used to improve blood-sugar control in adults with type 2 diabetes. Verzenio, whose generic name is abemaciclib, is a CDK4/6 inhibitor used in certain breast-cancer treatments.
Eli Lilly is sometimes confused with Novo Nordisk because both companies are major diabetes-drug manufacturers. Lilly also produces Mounjaro, whose active ingredient is tirzepatide. The company became one of the world's most valuable public pharmaceutical companies as investor interest in its diabetes and obesity medicines increased.